Skip to content
healthcare.dev

USTEKINUMAB-TTWE

NDC 82009-163, ustekinumab-ttwe, injection, solution, from Quallent Pharmaceuticals Health LLC.

Product NDC
82009-163
Status
Listed
Labeler
Quallent Pharmaceuticals Health LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761425
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82009-163 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • USTEKINUMAB130 mg/26mL

Pharmacologic classes

Interleukin-12 Antagonist [EPC]; Interleukin-12 Antagonists [MoA]; Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]

Package NDCNDC-11Package
82009-163-94820090163941 VIAL, SINGLE-USE in 1 CARTON (82009-163-94) / 26 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2b34392a-ecf6-41bd-8706-d4e9f0b25da8
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=82009-163

Use it

Look up 82009-163 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82009-163 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82009-163. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.